Synchrony Medical's LibAirty system for addressing mucus obstruction in COPD patients gained FDA clearance in July 2025.

Chronic obstructive pulmonary disease (COPD), an irreversible form of lung disease, is treated with prescription drugs, lifestyle changes, rehabilitation therapies, and surgery in certain cases. The ...

AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? Dr Rali: COPD diagnosis requires both clinical context ...

A Florence woman told us how a modern COPD treatment at Christ Hospital helped her to be able to do things she couldn't do before. I toured the White House to see Melania Trump's Christmas decorations ...

In May 2025, the FDA approved mepolizumab (Nucala) as a treatment for chronic obstructive pulmonary disease (COPD). Before any drug gets near a pharmacy shelf, it starts with years of basic science ...

“COPD is an urgent global health concern and a notoriously difficult-to-treat disease due to its heterogeneity, with no novel treatments approved in more than a decade,” said George D. Yancopoulos, ...

GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease: London, UK Saturday, February 7, 2026, 09:00 Hrs [IST] GSK plc announced the E ...

INDIANAPOLIS — An estimated 15 million adults in America have been diagnosed with COPD – chronic obstructive pulmonary disease – according to the Centers for Disease Control & Prevention, but the ...

MERCY MEDICAL CENTER. 57 YEAR OLD STEPHANIE HARRIS HAS BOTH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE, OR COPD. I STARTED SMOKING AROUND THE AGE OF 14 OR. 15. AND I COMPLETELY STOPPED MAYBE ...

Recent research suggests that certain biologic medications called monoclonal antibodies may help treat emphysema more effectively than some current therapies. These medications include benralizumab ...